SKYLINE · TAK-935-3001

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety and tolerability of soticlestat as adjunctive treatment in pediatric and young adult patients with Dravet syndrome. EudraCT: 2021-002480-22

Sponsor: TAKEDA

Phase: III

Area: Epilepsy

Open the current study catalogue